Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT05531240

Transurethral Prostate Resection (TURP) vs. Prostate Artery Embolization (PAE)

Conditions: Transurethral Resection of Prostate Syndrome, Prostate Hyperplasia, Embolization, Therapeutic

Sex: Male

Ages: 45 Years – N/A

Healthy volunteers: No

Phase: NA

Enrollment: 104

Sponsor: Uppsala University

Location: Helsingborgs Hospital Helsingborg Region Skånes

Summary

This study focuses on the treatment of benign prostatic hyperplasia which causes lower urinary tract symptoms. The purpose of the research project is to evaluate PAE in terms of both medical and health economic outcomes. To evaluate whether there are any differences in effect (IPSS), complications, costs and perceived quality of life compared with TUR-P.

Eligibility Criteria

Inclusion Criteria: * Benign prostatic hyperplasia where medical treatment has not helped or for other reasons has not been deemed applicable * IPSS\>=12 * Prostate volume \[40-100\] ml measured via transrectal ultrasound * Peak flow rate (Qmax) \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05531240). StuddyBuddy aggregates publicly available trial information.